Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20140212002Phase 3Completed
A Phase 3 trial of cyanocobalamin in diabetic neuropathy, type 2 diabetes mellitus (T2DM), sponsored by Department of Rehabilitation Medicine. Started Mar 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20140212002.